SARS‐CoV‐2 targets neurons of 3D human brain organoids
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, organoids can be cultivated over months and probably even years, thus enabling the investigation of tissue maturation in a disease context as shown for SARS-CoV-2 infections in brain organoids87”
From Human disease models in drug development (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SARS-CoV-2 tropism for neurons87 and cortical astrocytes88 or its preference for mature cell types and distinct neurotoxic effects were demonstrated in brain organoids.”
From Human disease models in drug development (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 7×
“ACE-2 is an entry receptor for SARS-CoV and efficient replication of SARS-CoV (SARS outbreak in the year 2003) and also depends on the expression level of ACE-2 (Li et al , 2003; Hoffmann et al , 2020).”
InfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“We adapted previously described protocol to differentiate iPSCs into brain organoids described earlier (Lancaster et al , 2013; Gabriel et al , 2016).”
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“However, emerging case reports showed that patients infected with SARS-CoV-2 suffered a sudden and complete loss of the olfactory function, stroke, and other severe neurological symptoms (Chen et al , 2020; Helms et al , 2020; Poyiadji et al , 2020; Sedaghat & Karimi, 2020; Virani et al , 2020).”
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 1×
“Cortical neurons are positioned basally to the VZ, forming a cortical plate ) (Lancaster & Knoblich, 2014; Giandomenico & Lancaster, 2017; Gopalakrishnan, 2019).”
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Research works printed but not linked: 1
- Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press
Cited by
Items 501–524 of 524
Stüdle, C., Nishihara, H., Wischnewski, S., Kulsvehagen, L., Perriot, S., Ishikawa, H., Schroten, H., Frank, S., Deigendesch, N., Du Pasquier, R., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24432018
Additional file 12 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636646
Additional file 4 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636622
Additional file 7 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636631
Additional file 13 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636649
Additional file 9 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636637
Additional file 1 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636613
Additional file 15 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636655
Additional file 2 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636616
Additional file 3 of Integrative single-cell RNA-seq analysis of vascularized cerebral organoids
Sato, Y., Asahi, T., & Kataoka, K. (2024) · Figshare · doi:10.6084/m9.figshare.26636619
Brain organoids as versatile models for neurotropic virus research
Mai, N. T. Q., & Moon, B.-S. (2025) · Organoid · doi:10.51335/organoid.2025.5.e10
“…2; ICAM-5, intercellular adhesion molecule 5; CXCR4, C-X-C chemokine receptor type 4; CCR5, CC chemokine receptor type 5. exhibited relatively low basal ACE2 expression levels, suggesting the involvement of additional neuron-specific host factors that may increase viral infection efficiency [72].”
Zhang, X., Jiang, Y., Wang, H., & Hu, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40423-8.00008-7
Wang, Y., & Gandy, S. (2026) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-032-16833-7_19
Asavapanumas, N., Chaiwijit, P., Suksatu, A., Kasemsinsup, S., Saikachain, N., Chantaraamporn, J., Chieowisaman, S., Nguantad, S., Jevapatarakul, D., Thungsatianpun, N., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-41177-z
COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain
Luna-Tenorio, E., Torres-Mendoza, J. N., Franco-Colín, M., Álvarez‐González, I., de la Cruz‐López, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261434258
Ganguli, S., Gupta, D., Kadumuri, R. V., Tandel, D., Ramaswamy, R., Krishnan, A. G., David, D. T., Bunk, S., Chavali, S., Harshan, K. H., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag271
“UTR at the two MBEs present in the SL1 and HVR.”
SARS-CoV-2 and neurological disorders
Zivaljic, M. (2022) · theses.fr (ABES) · doi:10.70675/3feed643z6732z4fbdzba74z397a36fc61d6
Exploration of autophagy modulation in cancer and infectious diseases
Bestion, E. (2021) · theses.fr (ABES) · doi:10.70675/3663f1cdz2637z4b11za0afza7e39569a2fc
Analyse du cycle du SARS-CoV-2 en modèle cellulaire par microscopie électronique à transmission
Eymieux, S. (2023) · theses.fr (ABES) · doi:10.70675/b2613d6dz2a78z4ce7za880z900e0b790d14
Moon, B.-S., Ahn, D., Park, J., Mai, N. T. Q., Jeong, D.-J., Hong, H., Yoon, S., Lee, S., Yoon, G. Y., Kim, C., et al. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103020
Acharya, A., Thurman, M., Sutar, D., Olasunkanmi, O. I., Reza, M. J., Dyavar, S. R., Végvári, Á., & Byrareddy, S. N. (2026) · Journal of Medical Virology · doi:10.1002/jmv.71086
“Therefore, it is important to understand the impact of SARS‐CoV‐2 on neurological complications among PWH. Published literature demonstrates a heterogeneous distribution of SARS‐CoV‐2 genomic RNA and proteins in the brain of COVID‐19 patients even after recovery from active disease [44, 50–53].”
ACC1 inhibition enhances BCG-induced trained immunity by reprogramming acetyl-CoA metabolism
Baydemir, İ., Nikolka, F., Bulut, O. P., Ferreira, A. V., Kılıç, G., Geckin, B., Kramer, R., Cuenca‐Escalona, J., Floor, E., Báez-Magaña, M., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.08.033
SARS-CoV-2 disrupts the integrity of a human blood-brain barrier model in the absence of infection
Jmii, H., Haverty, R., Rochfort, K. D., & Fletcher, N. F. (2026) · Journal of NeuroVirology · doi:10.1007/s13365-026-01337-3
Metadata
- Authors
- Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
- Affiliations
- Düsseldorf University Hospital (DE)
- Centre National de la Recherche Scientifique (FR)
- University of Cologne (DE)
- University Hospital Münster (DE)
- Corresponding author
- Schaal, Heiner
- Gopalakrishnan, Jay
- ORCID
- Ramani, Anand
- Müller, Lisa
- Ostermann, Philipp N
- Gabriel, Elke
- Müller‐Schiffmann, Andreas
- Mariappan, Aruljothi
- Goureau, Olivier
- Gruell, Henning
- Walker, Andreas
- Houwaart, Torsten
- Dilthey, Alexander
- Wohlgemuth, Kai
- Omran, Heymut
- Wieczorek, Dagmar
- Adams, Ortwin
- Timm, Jörg
- Korth, Carsten
- Schaal, Heiner
- Gopalakrishnan, Jay
- Venue
- The EMBO Journal
- Published
- 2020-09-23
- Volume
- 39
- Issue
- 20
- Pages
- e106230-e106230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7560208
- OpenAlex
- W3081536095
- Cited by
- 518
- References
- 63
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
- FWCI
- 42.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fritz Thyssen Stiftung (10.17.2.018MN)
- Juergen Manchot Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
- MeSH terms
- Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.